We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information for parents to explain what it means to have a positive screening result for carrying the cystic fibrosis (CF) gene.
This information explains what a suspected screening result for cystic fibrosis (CF) means.
Find out about the changes if you are exporting personal protective equipment (PPE) during the coronavirus pandemic.
Quadrant Pharmaceuticals Ltd has informed the MHRA of an error with the Patient Information Leaflets (PILs) in the listed batches of Cozaar 100mg film-coated tablets.
Biocon Pharma UK Limited are recalling a specific of batch Posaconazole 100mg Gastro-resistant Tablets due to an out of trend result for unspecified impurities during testing for stability.
Galderma (U.K.) Limited has informed the MHRA that a pallet of Loceryl 5% w/v Medicated Nail Lacquer from a batch licensed only for distribution in Ireland has been inadvertently placed into the UK supply chain due to a warehousing error...
Information for parents about isovaleric acidaemia (IVA) following a baby’s screening test result.
Information for British nationals who are victims of rape and sexual assault in Niue.
Information for parents about homocystinuria (HCU) following a baby’s screening test result.
Statement by Ambassador Barbara Woodward at the UN Security Council meeting on conflict-related sexual violence.
Product Safety Report for H Cosmetiques CI L'abidjanaise Cream presenting a serious chemical risk.
USV UK Limited has informed the MHRA that Sugammadex 100 mg/ml solution for injection (2 ml vial), batch number 35000347, may contain some vials that contain a low volume of solution; less than the label claim of 2 ml.
Find out about the symptoms of COVID-19, what to do if you or your child has them and when to get medical help.
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
Information for British nationals who are victims of rape and sexual assault in the Federated States of Micronesia.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.